Your browser doesn't support javascript.
loading
Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.
Desborough, Michael J R; Al-Shahi Salman, Rustam; Stanworth, Simon J; Havard, Diane; Woodhouse, Lisa J; Craig, Jennifer; Krishnan, Kailash; Brennan, Paul M; Dineen, Robert A; Coats, Tim J; Hepburn, Trish; Bath, Philip M; Sprigg, Nikola.
Affiliation
  • Desborough MJR; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Electronic address: michael.desborough@ouh.nhs.uk.
  • Al-Shahi Salman R; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Stanworth SJ; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Radcliffe Department of Medicine, University of Oxford, Oxford, UK; Transfusion Medicine, NHS Blood and Transplant, Oxford, UK.
  • Havard D; Stroke Trials Unit, University of Nottingham, Nottingham, UK.
  • Woodhouse LJ; Stroke Trials Unit, University of Nottingham, Nottingham, UK.
  • Craig J; Stroke Trials Unit, University of Nottingham, Nottingham, UK.
  • Krishnan K; Stroke, Medicine Division, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Brennan PM; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Dineen RA; Radiological Sciences, University of Nottingham, Nottingham, UK; NIHR Nottingham Biomedical Research Centre, Nottingham, UK.
  • Coats TJ; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
  • Hepburn T; Mental Health and Clinical Neurosciences, and Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
  • Bath PM; Stroke Trials Unit, University of Nottingham, Nottingham, UK; Stroke, Medicine Division, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Sprigg N; Stroke Trials Unit, University of Nottingham, Nottingham, UK; Stroke, Medicine Division, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Lancet Neurol ; 22(7): 557-567, 2023 07.
Article in En | MEDLINE | ID: mdl-37353276
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke / COVID-19 Type of study: Clinical_trials Limits: Aged / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Lancet Neurol Journal subject: NEUROLOGIA Year: 2023 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke / COVID-19 Type of study: Clinical_trials Limits: Aged / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Lancet Neurol Journal subject: NEUROLOGIA Year: 2023 Document type: Article Country of publication: Reino Unido